¡¡
Home > Products > Áø´Ü»ç¾÷ / Publication List
(1) ±èÁÖÇü, ±è¿µ¹è, ÃÖÁøÇõ, ±èÁ¤¹Ì, Á¤¼öÇö, ¼­±¤¿í. ´ëÀå¾ÏÀÇ ¿¹ÈÄÀÎÀڷμ­ thymidylate synthase À¯ÀüÀÚ ´ÙÇü¼ºÀÇ ÀÇÀÇ. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2004; 20(3):151-156. [Abstract] [PDF]
(2) Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, Kim NK. Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol. 2005; 23(11):2493-2501. [Abstract]
(3) Shin Myung Kang, Moo Suk Park, Joon Chang, Se Kyu Kim, Haeryoung Kim, Dong-Hwan Shin, Kyung Young Chung, Dae Joon Kim, Joo Hyuk Sohn, Sung Ho Choi, Jeongmi Kim, Eun Jin Yoon, Joo-Hang Kim. A Feasibility Study of Adenosine Triphosphate BasedChemotherapy Response Assay (ATP-CRA)as a Chemosensitivity Test for Lung Cancer. Cancer Research and Treatment. 2005; 37(4): 223-227.[Abstract] [PDF]
(4) Yoon DS, Park YN, Seo SJ, Ahn SP, Park JS, Chi HS. Putative Tumor Suppressor Gene Loci onChromosome 20q in Intrahepatic Cholangiocellular Carcinoma that were Found by Microsatellite Marker Analysis. Korean J Hepatobiliary Pancreat Surg. 2006;10(2):29-33. [Abstract]
(5) Kwang Wook Suh, Joo Hyung Kim,Do Yoon Kim,Young Bae Kim Chulho Lee and Sung Ho Choi. Which Gene is a Dominant Predictor of Response During FOLFOX Chemotherapy for the Treatment of Metastatic Colorectal Cancer, the MTHFR or XRCC1 Gene? ANNALS OF SURGICAL ONCOLOGY. 2006; 13(11):1379-1385. [Abstract]
(6) ¿À½Â¿±, ÀÌÀ縸, ÀÌÈ£¿ø, ±è¿µ¹è, Á¤¼öÇö, ±èÁ¤¹Ì, ¼­±¤¿í. »ê¹ß¼º ´ëÀå¾Ï¿¡¼­ Çö¹ÌºÎ¼öü ºÒ¾ÈÁ¤¼ºÀÇ ÀÓ»óº´¸®ÇÐÀû ÀÇÀÇ. ´ëÇѿܰúÇÐȸÁö. 2006; 71(6):420-425. [Abstract] [PDF]
(7) Hyun-Ah Kim ,Cha-Kyong Yom ,Byung-In Moon ,Kuk-Jin Choe, Sun-Hee Sung, Woon-Sup Han ,Hye-Young Choi ,Hye-Kyoung Kim, Heung-Kyu Park, Sung-Ho Choi ,Eun-Jin Yoon, Soo-Youn Oh. The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer. BREAST. 2007; 17(1):19-26. [Abstract]
(8) ÇãÁ¤¿í, ¹ÚÀ±¾Æ, ¼Õ½Â±¹, ÃÖ¼ºÈ£. ´ëÀå¾Ï¿¡¼­ Adenosine triphosphate based Chemotherapy ResponseAssay (ATP-CRA)¸¦ ÀÌ¿ëÇÑ In-vitro Ç×¾ÏÁ¦ °¨¼ö¼º °Ë»ç. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2007; 23(3):172-179.
[Abstract]
[PDF]
(9) ¹ÚÂù¼·, ÃÖ¼ºÈ£, ±èÈï´ë. ´ëÀå¾Ï¿¡¼­ Ç×¾ÏÁ¦ °¨¼ö¼º °Ë»çÀÇ ÀÓ»óÀû Ư¼º¿¡ °üÇÑ Ãʱ⿬±¸. ´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö. 2007; 23(5):358-364. [Abstract] [PDF]
(10) SU Woo, JW Bae, HG Kim, SH Choi, DH Kang, JB Lee, BW Koo. Correlation between the in vito ATP-based chemosensitivity assay and HER2/neu expression in women with breast cancer. The Journal of International Medical Research. 2007;35 (6):753-761. [Abstract]
(11) ¼³¹Ì¿µ, ÃÖ°æ¿î, ±èÁö¿¬, °­ÇöÁ¤, ½Åµ¿ÈÆ, ±èÀ͵Î, ÃÖÈ¿¼±, ¼­¼øÁ¤. ³­¼Ò»óÇǾϿ¡¼­ Çö¹ÌºÎ¼öü ºÒ¾ÈÁ¤¼º ºÐ¼®. ´ëÇѺ´¸®ÇÐȸÁö. 2007; 41:380-386. [Abstract] [PDF]
(12) YW Moon, SH Choi, YT Kim, JH Sohn, J Chang, SK Kim, MS Park, KY Chung, HJ Lee, JH Kim. Adenosine Triphosphate-Based Chemotherapy Response Assay (ATP-CRA)-guided Platinum-Based 2-Drug Chemotherapy for Unresectable Nonsmall-cellLung Cancer. CANCER. 2007;109(9):1829-1835. [Abstract] [PDF]
(13) Huh JW, Park YA, Jung EJ, Lee KY, Kwon JE, Sohn SK. Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. J Korean Med Sci. 2008;23(5):916-919. [Abstract] [PDF]
(14) Seung-Su Han, Sung Ho Choi, Yoo-Kyung Lee, Jae Weon Kim, Noh-Hyun Park, Yong-Sang Song, Hyo-Pyo Lee,Soon-Beom Kang. Predictive Value of Individualized Tumor Response Testing by ATP-Based Chemotherapy Response Assay in Ovarian Cancer. CANCER INVESTIGATION. 2008;26:426-430. [Abstract]
(15) JY Park, Y S Kim, SM Bang, WJ Hyung, SH Noh, SH Choi, SY Song. ATP-Based Chemotherapy Response Assay in Patients with Unresectable Gastric Cancer. ONCOLOGY. 2008;73:439-440.
[No abstract available]
(16) Jang TW, Oak CH, Chang HK, Suo SJ, Jung MH. EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung. Korean J Intern Med. 2009;24 (1):48-54. [Abstract] [PDF]
(17) Koo JS, Jung W, Shin E, Lee HD, Jeong J, Kim KH, Jeong H, Hong SW. Impact of grade, hormone receptor, and HER-2 status in women with breast cancer on response to specific chemotherapeutic agents by in vitro adenosine triphosphate-based chemotherapy response assay. J Korean Med Sci. 2009;24(6):1150-1157. [Abstract] [PDF]
(18) Moon YW, Sohn JH, Kim YT, Chang H, Jeong JH, Lee YJ, Chang J, Kim SK, Jung M, Hong S, Choi SH, Kim JH. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer. Anticancer Res. 2009;29(10):4243-4249. [Abstract]
(19) Y.B. Cho, W.Y. Lee, S.Y. Song, S.H. Choi, H.J. Shin, K.-D. Ahn, J.M. Lee, H.C. Kim, S.H. Yun, H.-K. Chun.In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA). Eur J Surg Oncol. 2009;35(9):951-956. [Abstract]
(20) Koo JS, Jung W, Jeong J. The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple Negative Breast Cancer. Jpn J Clin Oncol. 2009;39(9):560-568. [Abstract]
¡¡
(21) Young Joo Lee, In Kyu Park, Moo-Suk Park, Hye Jin Choi, Byoung Chul Cho,, Kyung Young Chung, Se Kyu Kim, Joon Chang, Jin Wook Moon, Hoguen Kim, Sung Ho Choi, Joo-Hang Kim. Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol. 2009;135(12):1647-1654. [Abstract]
(22) Park S, Woo Y, Kim H, Lee YC, Choi S, Hyung WJ, Noh SH. In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Gastric Cancer. J Gastric Cancer. 2010;10(4):155-161.
[Abstract]
[PDF]
(23) Hur H, Kang J, Kim NK, Min BS, Lee KY, Shin SJ, Keum KC, Choi J, Kim H, Choi SH, Lee MY. Thymidylate Synthase Gene Polymorphism Affects the Response to Preoperative 5-Fluorouracil Chemoradiation Therapy in Patients With Rectal Cancer. Int J Radiat Oncol Biol Phys. 2010 Oct 5. Epub ahead of print (PMID 20932673) [Abstract]
(24) ÃÖ¼ºÈ£, ±èºÀ¼®. Ç×¾ÏÁ¦¹ÝÀÀ¼º°Ë»ç: °³¿ä, ¹æ¹ý·Ð ¹× ATP-CRA¸¦ Ȱ¿ëÇÑ Àӻ󿬱¸°á°ú. BioWave.12(9) 2010 [Abstract] [PDF]
(25) Choi SK, Jeong J, Lee SA, Hwang SH, Ahn SG, Jung WH, Lee HD. Heterogeneous Chemosensitivity of Breast Cancer Determined by Adeonsine Triphosphate Based Chemotherapy Response Assay. J Breast Cancer. 2010;13(3):323-323. [Abstract] [PDF]
(26) Lee YJ, Cho BC, Jee SH, Moon JW, Kim SK, Chang J, Chung KY, Park IK, Choi SH, Kim JH. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol. 2010;28(3):487-492. [Abstract]
(27) Ahn SG, Jeong J, Choi SK, Hwang SH, Lee SA, Jung WH, Lee HD. Correlation of Early Systemic Recurrence with In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay in Stage II and III Breast Cancer Patients Treated with Doxorubicin-Based Chemotherapy. J Breast Cancer. 2011;14(Suppl 1):S50-S56. [Abstract]  [PDF]
(28) Lee JH, Kim MC, Oh SY, Kwon HC, Kim SH, Kwon KA, Lee S, Jeong JS, Choi SR, Kim HJ. Predictive Value of In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay in Advanced Gastric Cancer Patients Who Received Oral 5-Fluorouracil after Curative Resection. Cancer Res Treat. 2011;43(2):117-123. [Abstract]  [PDF]
¡¡
¡¡